Form 4: Encompass Health Director Kevin O'Connor Receives RSU Award from Dividend Reinvestment

Encompass Health Corp. Director Kevin J. O'Connor was awarded 15 restricted stock units on July 15, 2025, as part of a dividend reinvestment program for non-employee directors.

Summary

• Kevin J. O'Connor, a Director of Encompass Health Corp. (EHC), received an award of 15 Restricted Stock Units (RSUs).
• The award occurred on July 15, 2025, and was valued at $0 per unit, indicating it was a grant rather than a purchase.
• This RSU award is a result of additional RSUs being credited to non-employee directors' accounts in connection with common stock dividend payments.
• The number of RSUs credited is calculated based on the number of RSUs in the director's account on the dividend record date, the per share dividend, and the closing price on the dividend payment date.
• On July 15, 2025, Encompass Health paid a dividend of $0.17 per share, and the closing price of the common stock was $107.28.
• Following this transaction, Kevin J. O'Connor beneficially owns 9,881 shares of Encompass Health Common Stock.

Sentiment

Score: 6

Explanation: The transaction is a routine, expected RSU award to a director, reflecting standard compensation practices and aligning director interests with shareholders. It is neutral to slightly positive as it increases insider ownership, but not indicative of significant new information.

Positives

• Director Kevin J. O'Connor's beneficial ownership of Encompass Health stock increased by 15 shares, aligning his interests further with shareholders.
• The RSU award mechanism for non-employee directors, tied to dividend payments, demonstrates a structured approach to director compensation and equity alignment.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing, common across all publicly traded companies, reflecting a director's equity compensation and ownership changes. It does not provide broader industry trends.

Stakeholder Impact

• Shareholders: Slight positive impact as director's ownership increases, aligning interests.
• Employees/Customers/Suppliers/Creditors: No direct impact from this specific transaction.

Key Dates

Keywords

Encompass Health Corp, EHC, Kevin J. O'Connor, Form 4, SEC Filing, Restricted Stock Units, RSU, Director Compensation, Dividend Reinvestment, Insider Transaction, Beneficial Ownership